SDSabina Davidsson

Sabina Davidsson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sabina Davidsson has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Expression and genetic variants in stress-related signaling pathways in lethal and nonlethal prostate cancer.

    by Donghao Lu, Jessica Carlsson, Sabina Davidsson, Ove Andrén, Kathryn Penney, Lorelei A. Mucci, Unnur Anna Valdimarsdottir, Fang Fang, Katja Fall

    5032 Background: Recent data suggest that dysregulated stress-related signaling pathways may play a role in prostate cancer progression. We aim to compare expression of selected genes in the adrenergic, glucocorticoid, dopaminergic, and serotoninergic signaling pathways in tumor tissue from men with lethal and nonlethal prostate cancer, and to explore whether genetic variants may explain potential variation. Methods: We included 504 Swedish men diagnosed with incidental prostate cancer through TURP during 1977-1998 with up to 28 years of follow up. For those with tumor tissue available (N = 396), we measured mRNA expression of 223 selected genes included in predetermined stress-related signaling pathways. Using DNA from normal prostate tissue (N = 262), we genotyped 14 stress-related genes (29 SNPs). Associations of pathway gene expression and genetic variants with lethal prostate cancer were assessed as primary outcomes, and with tumor biomarkers as secondary outcomes. Results: Differential mRNA expression of genes in the serotoninergic pathway was associated with risk of lethal prostate cancer (p = 0.007); similar but somewhat weaker associations were noted for the adrenergic (p = 0.014) and glucocorticoid (p = 0.020) pathways. None of the studied genetic variants were associated with risk of lethal cancer after correcting for multiple testing, but a link was suggested for variants of HTR2A (rs2296972; OR 0.5, 95% CI 0.3-0.8, p = 0.002) and NR3CI (rs33388; OR 1.6, 95% CI 1.0-2.4, p = 0.035) genes (within the serotoninergic and glucocorticoid signaling pathways) in over-dominant models. No significant association between genotypes and mRNA expression of any individual gene in the corresponding pathways were observed. Genetic variants of HTR2A and NR3CI were associated with increased prostatic intraepithelial neoplasia and cell proliferation (all p < 0.05), respectively. Conclusions: Our findings lend some support to the hypothesis that dysregulated signaling in stress-related molecular pathways, particularly the serotoninergic, is involved in prostate cancer progression. If confirmed, this finding could open up new paths for research targeted towards reducing prostate cancer progression.

  • CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3+ regulatory T cells with respect to lethal prostate cancer

    by Sabina Davidsson, Anna-Lena Ohlson, Swen-Olof Andersson, Katja Fall, Allison Meisner, Michelangelo Fiorentino, Ove Andrén, Jennifer R Rider


  • Inflammation, Focal Atrophic Lesions, and Prostatic Intraepithelial Neoplasia with Respect to Risk of Lethal Prostate Cancer

    by Sabina Davidsson, Michelangelo Fiorentino, Ove Andrén, Fang Fang, Lorelei A. Mucci, Eberhard Varenhorst, Katja Fall, Jennifer R. Rider

    Background: A challenge in prostate cancer (PCa) management is identifying potentially lethal disease at diagnosis. Inflammation, focal prostatic atrophy, and prostatic intraepithelial neoplasia (PIN) are common in prostate tumor specimens, but it is not clear whether these lesions have prognostic significance. Methods: We conducted a case–control study nested in a cohort of men diagnosed with stage T1a-b PCa through transurethral resection of the prostate in Sweden. Cases are men who died of PCa (n = 228). Controls are men who survived more than 10 years after PCa diagnosis without metastases (n = 387). Slides were assessed for Gleason grade, inflammation, PIN, and four subtypes of focal prostatic atrophy: simple atrophy (SA), postatrophic hyperplasia (PAH), simple atrophy with cyst formation, and partial atrophy. We estimated OR and 95% CI for odds of lethal PCa with multivariable logistic regression. Results: Chronic inflammation and PIN were more frequently observed in tumors with PAH, but not SA. No specific type of atrophy or inflammation was significantly associated with lethal PCa overall, but there was a suggestion of a positive association for chronic inflammation. Independent of age, Gleason score, year of diagnosis, inflammation, and atrophy type, men with PIN were 89% more likely to die of PCa (95% CI: 1.04–3.42). Conclusion: Our data show that PIN, and perhaps presence of moderate or severe chronic inflammation, may have prognostic significance for PCa. Impact: Lesions in tumor adjacent tissue, and not just the tumor itself, may aid in identification of clinically relevant disease. Cancer Epidemiol Biomarkers Prev; 20(10); 2280–7. ©2011 AACR.


  • Open Access

    A miRNA expression signature that separates between normal and malignant prostate tissues

    by Jessica Carlsson, Sabina Davidsson, Gisela Helenius, Mats Karlsson, Zelmina Lubovac, Ove Andrén, Björn Olsson, Karin Klinga-Levan

    Background: MicroRNAs (miRNAs) constitute a class of small non-coding RNAs that post-transcriptionally regulate genes involved in several key biological processes and thus are involved in various diseases, including cancer. In this study we aimed to identify a miRNA expression signature that could be used to separate between normal and malignant prostate tissues.Results: Nine miRNAs were found to be differentially expressed (p<0.00001). With the exception of two samples, this expression signature could be used to separate between the normal and malignant tissues. A cross-validation procedure confirmed the generality of this expression signature. We also identified 16 miRNAs that possibly could be used as a complement to current methods for grading of prostate tumor tissues.Conclusions: We found an expression signature based on nine differentially expressed miRNAs that with high accuracy (85%) could classify the normal and malignant prostate tissues in patients from the Swedish Watchful Waiting cohort. The results show that there are significant differences in miRNA expression between normal and malignant prostate tissue, indicating that these small RNA molecules might be important in the biogenesis of prostate cancer and potentially useful for clinical diagnosis of the disease.